The Safety Profile of Biological Agents in Patients with Psoriasis and HIV: A Systematic Review

Saved in:

Bibliographic Details
Main Authors:	Niyaz Mostafa (Author), Kevin Phan (Author)
Format:	Book
Published:	European Medical Journal, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis
by: Caterina De Sarro, et al.
Published: (2024)

Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review
by: Wang Y, et al.
Published: (2023)

Update on biologic safety for patients with psoriasis during pregnancy
by: Martina L. Porter, et al.
Published: (2017)

Can Biologic Agents Improve Treatment Success in Obese Patients With Psoriasis Vulgaris: A Retrospective Review of 320 Patients With Psoriasis Vulgaris
by: Atıl Avcı, et al.
Published: (2024)

Should Mammography Be a Prerequisite Prior to Initiation of Biological Agents in Patients With Psoriasis?
by: Funda Tamer, et al.
Published: (2022)

Clinical evidence of therapy for genital psoriasis by biologic agents
by: Evgeny V. Sokolovskiy, et al.
Published: (2021)

Long-term safety of biologics in the treatment of psoriasis
by: Panchal MR, et al.
Published: (2013)

Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience
by: Federico Bardazzi, et al.
Published: (2017)

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
by: Farahnik B, et al.
Published: (2016)

SAFETY OF OPHTHALMIC BIOLOGICS: A SYSTEMATIC REVIEW
by: Ana Penedones, et al.
Published: (2015)

Safety and Efficacy of Long-Acting Injectable Agents for HIV-1: Systematic Review and Meta-Analysis
by: Wenjing Wang, et al.
Published: (2023)

The effect of biological agents on antinuclear antibody status in patients with psoriasis: A single-center study
by: Ömer Kutlu, et al.
Published: (2020)

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
by: Potestio L, et al.
Published: (2023)

Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
by: Aimilios Lallas, et al.
Published: (2016)

Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule
by: Michael Abrouk, BS
Published: (2016)

Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule
by: Michael Abrouk, et al.
Published: (2017)

Profiles of patients with psoriasis for appointment gene-engineering biological therapy - clinical justification
by: Alexander S. Zhukov, et al.
Published: (2020)

Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
by: el Hayderi L, et al.
Published: (2016)

Dose reduction of biologics in patients with plaque psoriasis: a review
by: C. A. M. van Riel, et al.
Published: (2024)

Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management
by: Al-Janabi A, et al.
Published: (2022)

Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics
by: Alan Menter, et al.
Published: (2020)

Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis
by: Richard B. Warren, et al.
Published: (2024)

Psoriasis in the Era of Targeted Cancer Therapeutics: A Systematic Review on De Novo and Pre-existing Psoriasis in Oncologic Patients Treated with Emerging Anti-neoplastic Agents
by: Vrinda Madan, et al.
Published: (2024)

Corrigendum: Dose reduction of biologics in patients with plaque psoriasis: a review
by: C. A. M. van Riel, et al.
Published: (2024)

Benefits and Safety of Chinese Herbal Medicine in Treating Psoriasis: An Overview of Systematic Reviews
by: Jie Zhang, et al.
Published: (2021)

Biologics use in Indian psoriasis patients
by: Murlidhar Rajagopalan, et al.
Published: (2016)

TREATMENT WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS: EFFICACY AND SAFETY OF CHANGEOVER
by: A. A. Baranov, et al.
Published: (2014)

Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management [Corrigendum]
by: Al-Janabi A, et al.
Published: (2022)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
by: Potestio L, et al.
Published: (2023)

Lipid profile in psoriasis patients
by: Bhat RM, et al.
Published: (2012)

Comparative efficacy and safety of thirteen biologic therapies for patients with moderate or severe psoriasis: A network meta-analysis
by: Guomei Xu, et al.
Published: (2019)

Two Cases of Immune Drift Phenomena Caused by Biologic Agents for Treating Psoriasis and Atopic Dermatitis
by: Ma X, et al.
Published: (2023)

Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis
by: Paula C. Luna, et al.
Published: (2023)

Drug Survival of Tumor Necrosis Factor-Alpha Inhibitors and Switched Subsequent Biologic Agents in Patients with Psoriasis: A Retrospective Study
by: Megumi Kishimoto, et al.
Published: (2023)

The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review
by: Osman A, et al.
Published: (2024)

Safety profiles of topical vitamin D3 in psoriasis patients: a retrospective large-scale study
by: Yamamoto A, et al.
Published: (2012)

Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Facial and Genital Psoriasis: A Systematic Review
by: Diva Amiri, et al.
Published: (2023)

The Actual Challenges of Biologics Treatment in Patients with Psoriasis
by: Andrey L. Bakulev
Published: (2020)

Biological therapy of psoriasis
by: Sivamani Raja, et al.
Published: (2010)

Biologics in the management of psoriasis
by: Jennifer D Bahner, et al.
Published: (2009)